Midea Issues Recall for 1.7 Million Air Conditioning Units Due to Mold Risk
Midea is recalling over 1.7 million window air conditioners due to potential mold growth caused by drainage issues, posing health risks such as respiratory infections. Find out if your unit is affected and how to get a refund or repair.
In a significant safety alert, Midea is recalling over 1.7 million of its window air conditioning units amid concerns about mold contamination. The recall covers models including U Window Air Conditioners and U+ Window Air Conditioners, which were manufactured and sold between March 2020 and May 2025. The recall was prompted by reports of a drainage malfunction that allows water to pool inside the units, creating ideal conditions for mold growth.
The U.S. Consumer Product Safety Commission (CPSC) has received at least 152 reports related to mold buildup in these units, with 17 consumers experiencing health issues such as coughing, sore throats, and respiratory infections, likely due to mold exposure. These units were sold at prominent retailers like Best Buy, Costco, and Home Depot, costing between $280 and $500. Nearly 46,000 units were also sold in Canada under various brands, including Comfort Aire, Danby, Frigidaire, Insignia, Keystone, LBG Products, Mr. Cool, Perfect Aire, and Sea Breeze.
Consumers are advised to check if their air conditioner model is part of the recall through the official channels. Midea offers a full refund or a free repair service. Customers can return their units with a provided free shipping label or cut the power cord and send a photo for a refund.
This recall underscores the importance of proper maintenance and timely inspections of home appliances to prevent health risks associated with mold and water damage.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
New Guidelines for Clinical Homologous Recombination Deficiency Testing Published
The Association for Molecular Pathology has published new best practice guidelines for homologous recombination deficiency testing, aiming to standardize assays and enhance cancer diagnosis and treatment outcomes.
Improving Dental Health in U.S. Adolescents: The Impact of School-Based Fluoride Programs
School-based fluoride varnish programs have proven effective in reducing cavities among U.S. children, offering a vital preventive approach in public health dentistry.
FDA Implements Daily Updates on Adverse Event Data for Enhanced Transparency
The FDA now publishes adverse event data daily, improving transparency and enabling quicker responses to safety concerns related to medications and biologics.
Disparities in Maternal Outcomes: Higher Risks for Marginalized Groups in Planned Repeat C-Sections
Research reveals that Black and Latinx women face higher risks of severe maternal health complications during planned repeat cesareans, highlighting ongoing racial disparities in obstetric care.